Literature DB >> 12667897

Selective blockade of spontaneous motor stereotypy via intrastriatal pharmacological manipulation.

Michael F Presti1, Heather M Mikes, Mark H Lewis.   

Abstract

Abnormal repetitive behavior, including stereotypy, is often observed in conjunction with developmental, neuropsychiatric, and genetic disorders. The present work employed the deer mouse model of spontaneous and persistent stereotypy to identify basal ganglia involvement in the mediation of these abnormal behaviors. To evaluate the hypothesis that stereotypy is expressed in these mice due to alterations in the activity of cortico-basal ganglia motor circuits, intrastriatal pharmacological manipulations aimed at attenuating the spontaneously emitted stereotypy were performed. Bilateral striatal infusion of the NMDA or dopamine D(1) receptor antagonists MK-801 or SCH23390, respectively, produced a substantial reduction in levels of stereotypic jumping without inhibiting nonstereotypic motor behavior. These findings support the hypothesis that environmentally related stereotypy is expressed as a consequence of elevated feedback activity occurring along motor circuits of the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667897     DOI: 10.1016/s0091-3057(02)01081-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  23 in total

Review 1.  Animal models of anxiety disorders.

Authors:  Joachim D K Uys; Dan J Stein; Willie M U Daniels; Brian H Harvey
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

2.  Indirect basal ganglia pathway mediation of repetitive behavior: attenuation by adenosine receptor agonists.

Authors:  Yoko Tanimura; Sasha Vaziri; Mark H Lewis
Journal:  Behav Brain Res       Date:  2010-02-21       Impact factor: 3.332

3.  Targeting Dopamine D2, Adenosine A2A, and Glutamate mGlu5 Receptors to Reduce Repetitive Behaviors in Deer Mice.

Authors:  Mark H Lewis; Christopher T Primiani; Amber M Muehlmann
Journal:  J Pharmacol Exp Ther       Date:  2019-02-11       Impact factor: 4.030

Review 4.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

Review 5.  Animal models of restricted repetitive behavior in autism.

Authors:  Mark H Lewis; Yoko Tanimura; Linda W Lee; James W Bodfish
Journal:  Behav Brain Res       Date:  2006-09-25       Impact factor: 3.332

6.  Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function.

Authors:  Somayeh Mohammadi; Majid Asadi-Shekaari; Mohsen Basiri; Mahdieh Parvan; Mohammad Shabani; Masoumeh Nozari
Journal:  Psychopharmacology (Berl)       Date:  2019-10-08       Impact factor: 4.530

Review 7.  Peromyscus maniculatus bairdii as a naturalistic mammalian model of obsessive-compulsive disorder: current status and future challenges.

Authors:  De Wet Wolmarans; Isabella M Scheepers; Dan J Stein; Brian H Harvey
Journal:  Metab Brain Dis       Date:  2017-12-06       Impact factor: 3.584

8.  Emergence of stereotypies in juvenile monkeys (Macaca mulatta) with neonatal amygdala or hippocampus lesions.

Authors:  M D Bauman; J E Toscano; B A Babineau; W A Mason; D G Amaral
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

9.  Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain.

Authors:  Bryce C Ryan; Nancy B Young; Jacqueline N Crawley; James W Bodfish; Sheryl S Moy
Journal:  Behav Brain Res       Date:  2009-11-24       Impact factor: 3.332

10.  Development of a mouse test for repetitive, restricted behaviors: relevance to autism.

Authors:  Sheryl S Moy; Jessica J Nadler; Michele D Poe; Randal J Nonneman; Nancy B Young; Beverly H Koller; Jacqueline N Crawley; Gary E Duncan; James W Bodfish
Journal:  Behav Brain Res       Date:  2007-11-04       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.